Clinical Trial Update: A Study of TAK-861 in People With Narcolepsy Type 1 [Phase 3]

View source ↗

Summary

Phase 3 trial of TAK-861 in Narcolepsy Type 1 has completed. No results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-861

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 1 | Phase 3 | Status: COMPLETED